Abstract:Molecular chaperones play a central role in protein disaggregation. However, the molecular determinants that regulate this process are poorly understood. Hsp104 is an AAA+ ATPase that disassembles stress granules and amyloids in yeast through collaboration with Hsp70 and Hsp40. In vitro studies show that Hsp104 processes different types of protein aggregates by partially translocating or threading polypeptides through the central pore of the hexamer. However, it is unclear how Hsp104 processing influences client protein function in vivo . The middle domain (MD) of Hsp104 regulates ATPase activity and interactions with Hsp70. Here, we tested how MD variants, Hsp104 A503S and Hsp104 A503V , process different protein aggregates. We establish that engineered MD variants fail to resolve stress granules but retain prion fragmentation activity required for prion propagation. Using the Sup35 prion protein, our in vitro and in vivo data indicate that the MD variants can disassemble Sup35 aggregates, but the disaggregated protein has reduced GTPase and translation termination activity. These results suggest that the middle domain can play a role in sensing certain substrates and plays an essential role in ensuring the processed protein is functional. Protein misfolding and assembly can lead to the formation highly ordered aggregates called amyloid. Amyloid is associated with several proteinopathies, including Alzheimer's and Parkinson's disease. Hsp104, the major chaperone disaggregase in yeast, fragments amyloid associated with yeast prions by working in concert with Hsp70 and Hsp40 chaperones to extract monomers from the amyloid in a partial-threading mechanism. Engineered variants within the middle domain (MD) of Hsp104, Hsp104 A503S and Hsp104 A503V , effectively disaggregate and reduce toxicity associated with human aggregating proteins. However, how the middle domain influences protein processing is not clearly defined. Our i n vitro and in vivo data suggest that the MD can help ensure that disaggregated proteins are functional immediately after processing.

The middle domain of Hsp104 can ensure substrates are functional after processing

Protein rescue from aggregates by powerful molecular chaperone machines

The molecular chaperone Hsp104—A molecular machine for protein disaggregation

Structural determinants for protein unfolding and translocation by the Hsp104 protein disaggregase

Spiral architecture of the Hsp104 disaggregase reveals the basis for polypeptide translocation

Early Steps of Protein Disaggregation by Hsp70 Chaperone and Class B J-Domain Proteins are Shaped by Hsp110

Substoichiometric Hsp104 regulates the genesis and persistence of self-replicable amyloid seeds of Sup35 prion domain

Heat Shock Protein 104 (HSP104) Chaperones Soluble Tau Via a Mechanism Distinct from Its Disaggregase Activity.

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Cooperation of Hsp70 and Hsp100 chaperone machines in protein disaggregation

Molecular dissection of amyloid disaggregation by human HSP70

Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70/HSP110 chaperones

Molecular chaperones cooperate with PIM1 protease in the degradation of misfolded proteins in mitochondria.

HSP110 is a modulator of amyloid beta (Aβ) aggregation and proteotoxicity

The chaperone HSPB1 prepares protein aggregates for resolubilization by HSP70

Disruption of ionic interactions between the nucleotide binding domain 1 (NBD1) and middle (M) domain in Hsp100 disaggregase unleashes toxic hyperactivity and partial independence from Hsp70

Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease

Small heat shock proteins sequester misfolding proteins in near-native conformation for cellular protection and efficient refolding

Chaperones in control of protein disaggregation

The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends